Future studies with ovarian hormone manipulation in ApoE4 female mice are now warranted to probe the mechanisms underlying AD pathology in postmenopausal female ApoE4 carriers, and to develop potential therapeutic targets for this population. The gene discussed is APOE; the disease is Alzheimer disease.